Overview

Improving Function,Welfare of Late-stage Cancer Subjects by ACC

Status:
Unknown status
Trial end date:
2019-05-31
Target enrollment:
Participant gender:
Summary
To improve the function and welfare of late stage solid cancer subjects by: - enabling subjects to benefit from a potentially promising drug under development - assessing initial evidence of improvement in Pain VAS score - assessing initial improvement in Performance Status (PS) - assessing initial improvement in oxygen saturation whenever it is feasible
Phase:
Phase 1
Details
Lead Sponsor:
Amorphical Ltd.
Treatments:
Calcium
Calcium Carbonate
Calcium, Dietary